Cita APA

Starodub, A. N., Ocean, A. J., Shah, M. A., Guarino, M. J., Picozzi, J., Vahdat, L. T., . . . Goldenberg, D. M. (2015). First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors. Clin Cancer Res.

Chicago Style Citation

Starodub, Alexander N., et al. "First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors." Clin Cancer Res 2015.

Cita MLA

Starodub, Alexander N., et al. "First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors." Clin Cancer Res 2015.